Femto Technologies Inc.

BYND Cannasoft Enterprises, Inc. engages in construction, licensing and operation of the cannabis farm. It also develops new CRM platform and new cannabis CRM platform. The company was founded on July 19, 2019 and is headquartered in Vancouver, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Femto Technologies, Inc. develops, markets and sells a proprietary client relationship management software known as Benefit CRM and Cannabis CRM platform. It also develops the EZ-G device, a patent-pending device that, combined with proprietary software. The company was founded on March 29, 2021 and is headquartered in Kiryat Motzkin, Israel.

ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (C.S.E.: BYND) ("BYND Cannasoft" or the "Company") today issued a letter to shareholders from its Chief Executive Officer and Director, Yftah Ben Yaackov.

CEO's Letter to Shareholders

A patent pending Double-faceted condom to enhance sexual pleasure marks BYND Cannasoft's entry in a multi-billion-dollar market A patent pending Double-faceted condom to enhance sexual pleasure marks BYND Cannasoft's entry in a multi-billion-dollar market

$10.97 Billion Potential Global Condom Market Could Be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises

Strengthened balance sheet, increased gross margins, and reduced expenses provide increased focus on growth based on BYND Cannasoft's CRM SaaS platform, medical cannabis, and EZ-G device Strengthened balance sheet, increased gross margins, and reduced expenses provide increased focus on growth based on BYND Cannasoft's CRM SaaS platform, medical cannabis, and EZ-G device

494% Increase in Assets to US$33 million Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Poised for Growth

Company reports 494% growth in 2022 assets to $33 million USD and strengthened balance sheet while increasing gross margins and reducing losses Company reports 494% growth in 2022 assets to $33 million USD and strengthened balance sheet while increasing gross margins and reducing losses

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Third Quarter 2022 Financial Results

International Searching Authority under the Patent Cooperation Treaty (“PCT”) provides non-binding opinion that one of the inventions comprising the EZ-G device is novel and inventive International Searching Authority under the Patent Cooperation Treaty (“PCT”) provides non-binding opinion that one of the inventions comprising the EZ-G device is novel and inventive

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Provides Update on International Patent Application Process for its Revolutionary EZ-G Device

VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 27, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today its Israeli subsidiary signed an agreement with Globus Pharma LTD, a subsidiary of Israeli-based Together Pharma Ltd (TA: TGTR), for the cultivation, production, and distribution of medical cannabis products that are expected to generate significant revenues for the company before costs of manufacturing and distribution fees. The manufacturing of the medical cannabis products will adhere to BYND Cannasoft's instructions and stringent standards. These products will be exclusively marketed and distributed by BYND Cannasoft in Israel through Globus Pharma. Due to their safety profile and strong therapeutic efficacy, the products are based on strains developed by Together Pharma and selected exclusively by BYND Cannasoft.

Tel Aviv Listed Together Pharma's Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises' Subsidiary Sign First Commercial Agreement for Medical Cannabis Products

VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that it entered into a consulting service with Matrix Medika, a developer of medical systems specialized in assisting companies in obtaining regulatory approval for medical devices under development. The service will be given as part of the agreement with Arkit Studio, a company that provides the service of characterization and design for the EZ-G Device.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. and Matrix Medika to Explore Further (FDA) Development of the EZ-G Device

VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 18, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that it received initial approval to engage in medical cannabis without direct contact with the substance from the Medical Cannabis Unit at the Ministry of Health of the State of Israel. Cannasoft received this initial approval as part of the process to obtain a full license that allows trading in medical cannabis products through an agreement with a licensed cannabis grower in Israel. Cannasoft is in the final stage of obtaining the full license.

Israel's Ministry of Health, through the Medical Cannabis Unit, granted BYND Cannasoft Enterprises Inc.'s Subsidiary, Cannasoft an Initial Approval to Engage in Medical Cannabis Without Direct Contact with the Substance

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) is pleased to announce that it has agreed to raise up to CAD$649,500 from certain investors by way of a non-brokered private placement. Specifically, the Company has agreed to issue up to 150,000 common shares at an issue price of $4.33 per share (the “Private Placement”).

Bynd Cannasoft Enterprises Inc. Announces $649,500 Non-Brokered Private Placement Financing

Beta version of software provided as SAAS includes BYND Cannasoft's proprietary C.R.M. System - Job Management (BENEFIT), as well as a module system for managing farms and greenhouses with varied crops (CANNASOFT) Beta version of software provided as SAAS includes BYND Cannasoft's proprietary C.R.M. System - Job Management (BENEFIT), as well as a module system for managing farms and greenhouses with varied crops (CANNASOFT)

BYND Cannasoft Enterprises Inc. Launches Beta Test for Managing Farms CRM Platform at Israel's Weizmann Institute of Science

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced today that, further to its news release of September 19, 2022, it has completed the purchase of all of the issued and outstanding shares of Zigi Carmel Initiatives & Investments Ltd. (“ZC”) from Carmel Zigdon. Under the terms of the share purchase agreement, the Company issued 7,920,000 common shares to the vendor. These shares are subject to a hold period and may not be traded in Canada before January 23, 2023.

Israeli Technology Company BYND Cannasoft Closes Acquisition of Zigi Carmel Investments Ltd. Valued at US $28 Million

AUSTIN, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Yftah Ben Yaackov, CEO of BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (CNSX:BYND.CN) (“BYND” or the “Company”), to discuss the Company's operations, innovations and outlook for the coming year.

BYND Cannasoft Enterprises CEO Discusses Latest Developments, Key Objectives in Audio Interview with SmallCapVoice.com

NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with BYND Cannasoft Enterprises Inc. Mark had the pleasure of recently conducting the Interview with Ben Yaackov, Chief Executive Officer of BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). Mr. Roberts diligently focused on questions he thought would be on the minds of most current and potential future shareholders.

Traders News Source Senior Editor, Mark Roberts Interviews Yftah Ben Yaackov, CEO BYND Cannasoft Enterprises Inc.

ZC owns the patent pending intellectual property for a CBD-based therapeutic device combined with software designed to treat phenomena related to women's health issues by regulating the flow of low-concentration CBD oils into the soft tissues of the female reproductive system ZC owns the patent pending intellectual property for a CBD-based therapeutic device combined with software designed to treat phenomena related to women's health issues by regulating the flow of low-concentration CBD oils into the soft tissues of the female reproductive system

REPEAT -- BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives & Investments Ltd. In a Share Swap Agreement Valued at US $28 Million

BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives & Investments Ltd. In a Share Swap Agreement Valued at US $28 Million

News for Femto Technologies Inc. Stock (BCAN)